LeBron James leaves behind Coke for deal with Pepsi


LeBron James leaves behind Coke for deal with Pepsi
FILE PHOTO: Oct 11, 2020; Lake Buena Vista, Florida, USA; Los Angeles Lakers forward LeBron James (23) celebrates after a play against the Miami Heat during the fourth quarter in game six of the 2020 NBA Finals at AdventHealth Arena. The Los Angeles Lakers won 106-93 to win the series. Mandatory Credit: Kim Klement-USA TODAY SportsMandatory Credit: Kim Klement-USA TODAY Sports/File Photo

In Summary

  • The Los Angeles Lakers superstar, a pitchman for Coca-Cola since entering the NBA in 2003, is set to land a new deal with PepsiCo
  • James reportedly will endorse Mountain Dew’s new “Rise Energy” beverage, part of the PepsiCo family, and he also could become the face of Pepsi Cola

LeBron James is changing teams in the cola wars.

The Los Angeles Lakers superstar, a pitchman for Coca-Cola since entering the NBA in 2003, is set to land a new deal with PepsiCo.

The news was first reported Friday by Front Office Sports, then confirmed by ESPN.

James reportedly will endorse Mountain Dew’s new “Rise Energy” beverage, part of the PepsiCo family, and he also could become the face of Pepsi Cola.

His deal with Coca-Cola ended last year after he spent years hawking Sprite and Powerade.

A Coca-Cola spokesperson told Front Office Sports, “LeBron’s contract came up at a time when both he and The Coca-Cola Company were actively reviewing all of its resources to make sure it was investing in places that ensured long-term growth. After many discussions with LeBron and his team, we mutually agreed to part ways.”

PepsiCo and James’ representatives refused to comment on the report, per Front Office Sports.

James ranked fifth on Forbes’ 2020 list of the world’s highest-paid athletes, with his $60 million in endorsements for the year tying for second on the list with the No. 8 Tiger Woods. No. 1 Roger Federer was tops in endorsement money at $100 million.

For Citizen TV updates
Join @citizentvke Telegram channel



Video Of The Day: KEMRI scientists examine safety of anti-malarial drugs in first trimester of pregnancy

Avatar
Story By Reuters
More by this author